Abstract
To reduce the transmission of SARS-CoV-2 most countries closed schools, despite uncertainty if school closures are an effective containment measure. At the onset of the pandemic, Swedish upper secondary schools moved to online instruction while lower secondary school remained open. This allows for a comparison of parents and teachers differently exposed to open and closed schools, but otherwise facing similar conditions. Leveraging rich Swedish register data, we connect all students and teachers in Sweden to their families and study the impact of moving to online instruction on the incidence of SARS-CoV-2 and COVID-19. We find that among parents, exposure to open rather than closed schools resulted in a small increase in PCR-confirmed infections [OR 1.15; CI95 1.03–1.27]. Among lower secondary teachers the infection rate doubled relative to upper secondary teachers [OR 2.01; CI95 1.52–2.67]. This spilled over to the partners of lower secondary teachers who had a higher infection rate than their upper secondary counterparts [OR 1.30; CI95 1.00–1.68]. When analyzing COVID-19 diagnoses from healthcare visits and the incidence of severe health outcomes, results are similar for teachers but somewhat weaker for parents and teachers’ partners. The results for parents indicate that keeping lower secondary schools open had minor consequences for the transmission of SARS-CoV-2 in society. The results for teachers suggest that measures to protect teachers could be considered.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We are grateful for financial support from Handelsbankens forskningssiftelser.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This project was approved by the Swedish Ethical Approval Board on May 19, 2020 (decision number 2020-02323).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
This project was approved by the Swedish Ethical Approval Board (Etikprövingsnämnden) on May 19, 2020 (decision number 2020-02323). The data on PCR tests was first made available on July 28, 2020. Due to reporting errors, the PCR data was updated on October 2, 2020. Data on healthcare outcomes was received on September 24, 2020. We are grateful for financial support from Handelsbankens forskningssiftelser, and for comments by Jonas Björk, Lena Edlund, Jens Engleson, Tove Fall, Erik Grönqvist, Emily Oster, Oskar Nordström Skans and David Strömberg. Data is available from Statistics Sweden, the Public Health Agency, and the National Board of Health and Welfare following an ethical review.
Data Availability
The data used for the analysis have been obtained by combining several administrative registers collected and held by three government agencies: Statistics Sweden, The National Board of Health and Welfare and The Public Health Authority. Access to these data sets is restricted by national regulations, but any researcher wishing to replicate our results can apply for access through these agencies. Since the study involves sensitive individual level data, getting access to the data also requires approval from an Ethics Board.
